-------------------- Dr Peter Greaves -------------------------------

Dr Greaves was appointed as a member of COC in April 2009. He is a medical graduate trained in human histopathology. His main interests have been in the pre-clinical safety evaluation of new therapies and he has published extensively in this area. He was previously a member of the Veterinary Products Committee.

Declaration of Interests

Personal Interest

Consultancies:

Actelion Pharmaceuticals Ltd, Allschwil, Switzerland

Astellas Pharma Europe Ltd

AstraZeneca, Alderley Park, UK

INEOS Healthcare, Warrington UK

Nono Nordisk A/S, Malov, Denmark

Pfizer, Sandwich, UK

Shire Pharmaceutical Development Ltd, Basingstoke, UK

Synosia Therapeutics, South San Francisco, USA

Teva Pharmaceuticals Ltd, Israel